{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:58:57Z","timestamp":1761562737218,"version":"3.44.0"},"reference-count":22,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,1,14]]},"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:p>Tumour lysis syndrome (TLS) is a constellation of metabolic derangements caused by lysis of tumour cells. It is an oncological emergency that is considered a rare occurrence in multiple myeloma (MM) and usually occurs after patients have been treated with chemotherapy. We describe a very rare case of TLS occurring before the official diagnosis or treatment of MM. We report infrequent karyotype abnormalities, including loss of 17p13.1 (<jats:italic>TP53<\/jats:italic> mutation), t(4;14) (<jats:italic>FGFR3\/IGH fusion<\/jats:italic>) and monosomy 13, that have not been explicitly described in association with spontaneous tumour lysis syndrome (STLS) in MM. This case adds to the sparse literature available on STLS in MM, which is a life-threatening situation requiring urgent medical intervention.<\/jats:p>","DOI":"10.1136\/bcr-2019-234122","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T15:40:43Z","timestamp":1612539643000},"page":"e234122","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Spontaneous tumour lysis syndrome in multiple myeloma with loss of 17p13.1, t(4;14) and monosomy 13"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1717-9396","authenticated-orcid":false,"given":"Bushra","family":"Tbakhi","sequence":"first","affiliation":[{"name":"Hematology\/Oncology, University of Rochester, Rochester, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Hanna","sequence":"additional","affiliation":[{"name":"Internal Medicine, Unity Hospital, Rochester, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazan","family":"Samhouri","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deeraj","family":"Lingutla","sequence":"additional","affiliation":[{"name":"Internal Medicine, Unity Hospital, Rochester, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"2025082710400626000_14.2.e234122.1","unstructured":"Arrambide K , Toto RD . Tumor lysis syndrome. seminars in nephrology, 1993."},{"key":"2025082710400626000_14.2.e234122.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05094.x"},{"key":"2025082710400626000_14.2.e234122.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08143.x"},{"key":"2025082710400626000_14.2.e234122.4","doi-asserted-by":"publisher","DOI":"10.4066\/AMJ.2013.1592"},{"key":"2025082710400626000_14.2.e234122.5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/20009666.2020.1781748","article-title":"A rare case of spontaneous tumor lysis syndrome in multiple myeloma","volume":"10","author":"Aldabain","year":"2020","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"2025082710400626000_14.2.e234122.6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12288-016-0731-6","article-title":"Tumor lysis syndrome in multiple myeloma: an increasingly recognized Risk-A report of seven cases","volume":"33","author":"Singh","year":"2017","journal-title":"Indian J Hematol Blood Transfus"},{"key":"2025082710400626000_14.2.e234122.7","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9620520","article-title":"Spontaneous tumour lysis syndrome in a multiple myeloma","volume":"2016","author":"Huzmeli","year":"2016","journal-title":"Case Rep Med"},{"key":"2025082710400626000_14.2.e234122.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0904569"},{"key":"2025082710400626000_14.2.e234122.9","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03150312"},{"key":"2025082710400626000_14.2.e234122.10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01467.x"},{"key":"2025082710400626000_14.2.e234122.11","unstructured":"Edeani A , Shirali A . Tumor lysis syndrome. American Society of Nephrology, 2016."},{"key":"2025082710400626000_14.2.e234122.12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3816\/CLM.2006.n.064","article-title":"Bortezomib-Induced tumor lysis syndrome in multiple myeloma","volume":"7","author":"Sezer","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"key":"2025082710400626000_14.2.e234122.13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404524"},{"key":"2025082710400626000_14.2.e234122.14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.9.3025"},{"key":"2025082710400626000_14.2.e234122.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1675"},{"key":"2025082710400626000_14.2.e234122.16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02488.x"},{"key":"2025082710400626000_14.2.e234122.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3017"},{"key":"2025082710400626000_14.2.e234122.18","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870901)60:5<1060::AID-CNCR2820600522>3.0.CO;2-3"},{"key":"2025082710400626000_14.2.e234122.19","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.21873\/anticanres.11274","article-title":"High risk of tumor lysis syndrome in symptomatic patients with multiple myeloma with renal dysfunction treated with bortezomib","volume":"36","author":"Oiwa","year":"2016","journal-title":"Anticancer Res"},{"key":"2025082710400626000_14.2.e234122.20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.23876\/j.krcp.19.042","article-title":"Acute kidney injury in the patient with cancer","volume":"38","author":"Rosner","year":"2019","journal-title":"Kidney Res Clin Pract"},{"key":"2025082710400626000_14.2.e234122.21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/nep.12806","article-title":"Impact of dialysis requirement on outcomes in tumor lysis syndrome","volume":"22","author":"Garimella","year":"2017","journal-title":"Nephrology"},{"key":"2025082710400626000_14.2.e234122.22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0177"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-234122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:40:15Z","timestamp":1756316415000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-234122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,5]]},"published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1136\/bcr-2019-234122"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-234122","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}